The significance of QT interval in drug development

被引：168
作者：
Shah, RR [1 ]
机构：
[1] Med Controls Agcy, London SW8 5NQ, England
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 54卷 / 02期
关键词：
astemizole; Bazett; cisapride; clinical trials; dose schedules; droperidol; drug development; Fridericia; grepafloxacin; halofantrine; metabolites; pharmacogenetics; pimozide; prenylamine; QT interval; sertindole; stereoselectivity; terfenadine; terodiline; torsade de pointes; ziprasidone;
D O I：
10.1046/j.1365-2125.2002.01627.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：188 / 202
页数：15
相关论文
共 101 条
[1]   Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation [J].
Abernethy, DR ;
Wesche, DL ;
Barbey, JT ;
Ohrt, C ;
Mohanty, S ;
Pezzullo, JC ;
Schuster, BG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (03) :231-237
[2]   TORSADE DEPOINTES DUE TO QUINIDINE - OBSERVATIONS IN 31 PATIENTS [J].
BAUMAN, JL ;
BAUERNFEIND, RA ;
HOFF, JV ;
STRASBERG, B ;
SWIRYN, S ;
ROSEN, KM .
AMERICAN HEART JOURNAL, 1984, 107 (03) :425-430
[3]   BASIC MECHANISMS UNDERLYING PRENYLAMINE-INDUCED TORSADE DE POINTES - DIFFERENCES BETWEEN PRENYLAMINE AND FENDILINE DUE TO BASIC ACTIONS OF THE ISOMERS [J].
BAYER, R ;
SCHWARZMAIER, J ;
PERNICE, R .
CURRENT MEDICAL RESEARCH AND OPINION, 1988, 11 (04) :254-272
[4]   Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors [J].
Bernardi, M ;
Calandra, S ;
Colantoni, A ;
Trevisani, F ;
Raimondo, ML ;
Sica, G ;
Schepis, F ;
Mandini, M ;
Simoni, P ;
Contin, M ;
Raimondo, G .
HEPATOLOGY, 1998, 27 (01) :28-34
[5]  
BILLON N, 1995, FUND CLIN PHARM, V9, P88
[6]   Assessment of QTc prolongation for non-cardiac-related drugs from a drug development perspective [J].
Bonate, PL ;
Russell, T .
JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (04) :349-358
[7]   Temporal decline in filling prescriptions for terfenadine closely in time with those for either ketoconazole or erythromycin [J].
Burkhart, GA ;
Sevka, MJ ;
Temple, R ;
Honig, PK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (01) :93-96
[8]   Abnormalities of the QT interval in primary disorders of autonomic failure [J].
Choy, AMJ ;
Lang, CC ;
Roden, DM ;
Robertson, D ;
Wood, AJJ ;
Robertson, RM ;
Biaggioni, I .
AMERICAN HEART JOURNAL, 1998, 136 (04) :664-671
[9]   TORSADE-DE-POINTES AFTER ASTEMIZOLE OVERDOSE [J].
CRAFT, TM .
BRITISH MEDICAL JOURNAL, 1986, 292 (6521) :660-660
[10]   QT interval prolongation by noncardiovascular drugs: issues and solutions for novel drug development [J].
Crumb, W ;
Cavero, I .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (07) :270-280
12345678910